For the lymphoma model, however, treatment with IL-12 (pre-post, pre-only or post-only) significantly reduced tumor growth (%T/C < 50%) as compared to the vehicle control, whereas the results for G-CSF were not significant. The gene discussed is CSF3; the disease is lymphoma.